MedPath

ONO-4578-05:ONO-4578 Phase 1 Study

Phase 1
Conditions
on-small cell lung cancer
Registration Number
JPRN-jRCT2031200346
Lead Sponsor
Osawa Masahiro
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

1. Clinical stage III B/ III C with unsuitable for radical irradiation, Clinical stage IV or recurrent non-small cell lung cancer
2. Life expectancy of at least 3 months
3. Patients with ECOG performance status 0 or 1

Exclusion Criteria

1. Patients with severe complication
2. Patients with multiple primary cancers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety, tolerability
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath